Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors-Reference-Cited by-同舟云学术

Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors

Published:2020-07 Issue:7 Volume:19 Page:1236-1247
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Mei Shutao,Ayala Rochelle,Ramarathinam Sri H.^ORCID,Illing Patricia T.^ORCID,Faridi Pouya^ORCID,Song Jiangning^ORCID,Purcell Anthony W.^ORCID,Croft Nathan P.^ORCID

Funder

Department of Health | National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference81 articles.

1. A molecular basis for the presentation of phosphorylated peptides by HLA-B antigens;Alpízar;Mol. Cell. Proteomics,2017

2. Varied role of ubiquitylation in generating MHC class I peptide ligands;Wei;J. Immunol,2017

3. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter;Beresford;Nat. Immunol,2001

4. T cell epitopes and post-translationally modified epitopes in type 1 diabetes;McGinty;Current Diabetes Reports,2015

5. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications;Sidney;BMC Immunol,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes;Nature Communications;2024-08-30

2. Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrain;Mass Spectrometry Reviews;2024-08-16

3. Immunopeptidomics in the cancer immunotherapy era;Exploration of Targeted Anti-tumor Therapy;2024-07-17

4. Targeted protein editing technique in living mammalian cells by peptide-fused PNGase;hLife;2024-07

5. HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease;Brain;2024-03-01